How Low Should We Go?

A major study called SPRINT from Case Western Reserve seemed to indicate that lowering blood pressure to 120 Systolic might lower all-cause mortality by 25% in non-diabetic patients.  The study is controversial because the results conflict somewhat with the earlier ACCORD study that included diabetic patients.  We can expect guideline writers to lower BP goals in the near future.  That might be a good thing, but it would be much better if we added natural therapies like garlic, magnesium, and herbal preparations rather than adding another drug or two and their potential for new side effects.

See the NEJM, Nov. 9, 2015

Celebration of HealthAssociation website